L. Volkov

发表

Modular sub-monomeric cell-penetrating guanidine-rich peptoids – synthesis, assembly and biological evaluation

C. Lavoie, Albane Neckebroeck, É. Marsault, 2017 .

Des-Arg9-bradykinin increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice.

L. Volkov, P. Sirois, G. Bkaily, 2003, European journal of pharmacology.

Effects of the angiotensin‐converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl‐N‐Ser‐Asp‐Lys‐Pro concentrations

V. Praloran, J. Aldigier, V. Lorgeot, 1997, European journal of clinical investigation.

Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells.

V. Praloran, P. Hervé, P. Charbord, 1997, Experimental hematology.

Macrocyclic cell penetrating peptides: a study of structure-penetration properties.

C. Lavoie, É. Marsault, Heidi Larkin, 2015, Bioconjugate chemistry.

Aggregation of cellular prion protein is initiated by proximity‐induced dimerization

X. Roucou, Cyntia Bissonnette, L. Volkov, 2007, Journal of neurochemistry.

Selective Modulation of Wild Type Receptor Functions by Mutants of G-Protein-coupled Receptors*

Christian Le Gouill, Jean-Luc Parent, J. Stankova, 1999, The Journal of Biological Chemistry.

Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non‐neuronal cells

X. Roucou, Cyntia Bissonnette, L. Volkov, 2006, Journal of neurochemistry.

The tetrapeptide AcSDKP, a physiological inhibitor of normal cell proliferation, reduces the S phase entry of continuous cell lines.

V. Praloran, F. Coudert, P. Quéré, 1996, Experimental cell research.

Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models

N. Rivard, L. Volkov, M. R. Farias, 2009, Cancer Chemotherapy and Pharmacology.